112 related articles for article (PubMed ID: 22887973)
1. The 'up-down' sign of acute ocular surface drug toxicity.
Dua HS; Otri AM; Said DG; Faraj LA
Br J Ophthalmol; 2012 Nov; 96(11):1439-40. PubMed ID: 22887973
[No Abstract] [Full Text] [Related]
2. [Ocular pseudopemphigoid after topical drug administration].
Anders N; Wollensak J
Klin Monbl Augenheilkd; 1994 Aug; 205(2):61-4. PubMed ID: 7967407
[TBL] [Abstract][Full Text] [Related]
3. The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.
Cho HK; Park MH; Moon JI
Ophthalmic Res; 2012; 48(3):139-45. PubMed ID: 22572974
[TBL] [Abstract][Full Text] [Related]
4. Urticaria-angioedema due to carboxymethylcellulose eye drops.
Carbonell A; Miralles JC; Escudero AI; Martínez A; Pineda F; Aldana D
J Investig Allergol Clin Immunol; 2012; 22(4):288-9. PubMed ID: 22812199
[No Abstract] [Full Text] [Related]
5. Minocycline-induced hyperpigmentation of the skin, sclera, and palpebral conjunctiva.
Skorin L; Turpin S
Can J Ophthalmol; 2017 Apr; 52(2):e79-e81. PubMed ID: 28457312
[No Abstract] [Full Text] [Related]
6. Drug-induced conjunctival cicatrisation.
Broadway D
Dev Ophthalmol; 1997; 28():86-101. PubMed ID: 9386931
[No Abstract] [Full Text] [Related]
7. [Corneal, conjunctival and lacrimal changes (excluding dry eye)].
George JL
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():109-45. PubMed ID: 2866039
[No Abstract] [Full Text] [Related]
8. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
Torkildsen G; O'Brien TP
Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
[TBL] [Abstract][Full Text] [Related]
9. [Be aware of toxicity of eye drops to ocular surface].
Yan XM
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):387-9. PubMed ID: 15938798
[TBL] [Abstract][Full Text] [Related]
10. Contact allergy following administration of eyedrops and eye ointments.
Kruyswijk MR; van Driel LM; Polak BC; Go-Sennema AA
Doc Ophthalmol; 1980 Apr; 48(2):251-3. PubMed ID: 7398524
[TBL] [Abstract][Full Text] [Related]
11. [Conjunctival changes related to topical treatment and effectiveness of surgery in glaucoma].
Stefan C; Nenciu A; Balas M; Neacşu A; Dachin L; Ardelean C
Oftalmologia; 2003; 59(4):19-23. PubMed ID: 15083680
[TBL] [Abstract][Full Text] [Related]
12. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel.
Dalvin LA; Garcia MD; Salomão DR; Iezzi R; Barkmeier AJ
Ophthalmology; 2016 Oct; 123(10):2262-3. PubMed ID: 27324684
[No Abstract] [Full Text] [Related]
13. Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface.
Bai T; Huang J; Wang W
Cutan Ocul Toxicol; 2010 Dec; 29(4):247-53. PubMed ID: 20550489
[TBL] [Abstract][Full Text] [Related]
14. Systemic effects of eye drops.
Davidson SI
Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
[No Abstract] [Full Text] [Related]
15. Conjunctival Necrosis Masquerading as Necrotizing Scleritis.
Agarwal M; Elizabeth A; George R; Biswas J
Ocul Immunol Inflamm; 2018; 26(8):1223-1224. PubMed ID: 28910555
[No Abstract] [Full Text] [Related]
16. Topical administration of chloramphenicol can induce acute hepatitis.
Doshi B; Sarkar S
BMJ; 2009 Jun; 338():b1699. PubMed ID: 19525305
[No Abstract] [Full Text] [Related]
17. [New aspects on systemic adverse effects of ocular drugs].
Uusitalo H; Salminen L
Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504
[No Abstract] [Full Text] [Related]
18. Survey of patients taking topical medication at their first presentation to eye casualty.
Buckley SA
BMJ; 1990 Jun; 300(6738):1497-8. PubMed ID: 2142610
[No Abstract] [Full Text] [Related]
19. An uncommon ocular manifestation of pemphigus vulgaris: conjunctival mass.
Uludag HA; Uysal Y; Kucukevcilioglu M; Ceylan OM; Onguru O; Arca E
Ocul Immunol Inflamm; 2013 Oct; 21(5):400-2. PubMed ID: 23718286
[No Abstract] [Full Text] [Related]
20. The effects of antiglaucomatous agents on conjunctiva used for various durations.
Aritürk N; Oge I; Baris S; Erkan D; Süllü Y; Koc F
Int Ophthalmol; 1996-1997; 20(1-3):57-62. PubMed ID: 9112165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
